Journal of Clinical Psychiatry Issue 69(5)

Diagnostic Dilemmas and Clinical Correlates of Mixed States in Bipolar Disorder

Treating Movement Disorders and Akathisia as Side Effects of Antipsychotic Pharmacotherapy

The Role of Psychosocial Interventions in Bipolar II Disorder: What Do We Know?

Trauma and Posttraumatic Stress Disorder in the Elderly: Findings From a German Community Study

A Randomized, Double-Blind, Placebo-Controlled Add-On Trial of Quetiapine in Outpatients With Bipolar Disorder and Alcohol Use Disorders

Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity: A 16-Week Randomized, Double-Blind, Placebo-Controlled Trial

Long-Term Stability of Cognitive Impairment in Bipolar Disorder: A 2-Year Follow-Up Study of Lithium-Treated Euthymic Bipolar Patients

Aripiprazole Augmentation in Clozapine-Treated Patients With Refractory Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial

Family Treatment for Bipolar Disorder: Family Impairment by Treatment Interactions

Predicted Risk of Diabetes and Coronary Heart Disease in Patients With Schizophrenia: Aripiprazole Versus Standard of Care

Diagnosis of Unipolar Depression Following Initial Identification of Bipolar Disorder: A Common and Costly Misdiagnosis

Life-Threatening Clozapine-Induced Gastrointestinal Hypomotility: An Analysis of 102 Cases

Efficacy of Quetiapine Monotherapy for the Treatment of Depressive Episodes in Bipolar I Disorder: A Post Hoc Analysis of Combined Results From 2 Double-Blind, Randomized, Placebo-Controlled Studies

A Double-Blind, Placebo-Controlled Study of the Opiate Antagonist Naltrexone in the Treatment of Pathological Gambling Urges

An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia

Depression, Diabetes, and Glycemic Control in an American Indian Community

Depression Comorbidity and Antidepressant Use in Veterans With Chronic Hepatitis C: Results From a Retrospective Chart Review

Efficacy and Tolerability of Oral Paliperidone Extended-Release Tablets in the Treatment of Acute Schizophrenia: Pooled Data From Three 6-Week, Placebo-Controlled Studies

Mood Disorders: Assessment, Risk Factors, and Outcome

Developing a 10-Item Mania Scale From the Parent General Behavior Inventory for Children and Adolescents

A Parent General Behavior Inventory Subscale to Measure Sleep Disturbance in Pediatric Bipolar Disorder

One-Year Course and Predictors of Outcome of Adolescent Depression: A Case-Control Study in Finland

Psychological Adjustment of Adolescents 18 Months After the Terrorist Attack in Beslan, Russia: A Cross-Sectional Study

ASCP Corner: Antipsychotic Polypharmacy, Part 2: Why Use 2 Antipsychotics When 1 Is Not Good Enough?

A Case of Sodium Oxybate Treatment of Tardive Dyskinesia and Bipolar Disorder

Aripiprazole Joins the Family of Second-Generation Mood Stabilizers

Intrinsic Activity of Aripiprazole Is Not 30% of Dopamine, But Only About 6% Under Ideal Antipsychotic Therapy

Reply to "Intrinsic Activity of Aripiprazole Is Not 30% of Dopamine, But Only About 6% Under Ideal Antipsychotic Therapy"

Does Venlafaxine Maintenance Therapy Prevent Depression Recurrences or Drug Discontinuation Reactions?

Reply ro "Does Venlafaxine Maintenance Therapy Prevent Depresion Recurrences or Drug Discontinuation Reactions?"